A team of scientists at the University of Michigan hopes to replicate the results in cells from diabetic patients and open ...

A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of diabetic nephropathy (DN) and explores its potential ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...

Many people diagnosed with type 2 diabetes often wonder, “Why me? I hardly eat sugar or sweets.” It’s a common belief that ...

Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a five-year period and could ...

GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...

Scientists at Western University have discovered that a natural compound found in sweet oranges and tangerines, called ...

The researchers suggest that sleep deprivation may exacerbate the inflammatory state associated with obesity by increasing ...

Legislatures, governors, government agencies, and plaintiff attorneys are taking action against ultra-processed foods, but ...

Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases.

More people are using wearable glucose monitors as the appetite for personalized health data grows beyond smartwatches and fitness trackers. For years, people with diabetes have used continuous ...

Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...